COMMUNIQUÉS West-GlobeNewswire

Novartis rises to second place in 2018 Access to Medicine Index

20/11/2018 - 14:16

Company leads the industry in access-to-medicine management thanks to long- term commitment, as well as ongoing innovation in access to healthcare Novartis moves up one position from number 3 in 2016 Report highlights [...]

Novan to Present at Piper Jaffray 30th Annual Healthcare Conference

20/11/2018 - 14:05

MORRISVILLE, N.C., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that Paula Brown Stafford, Chief Development Officer, and Nathan Stasko, President and Chief [...]

Nemaura Signs License and Distribution Agreement for SugarBEAT® Commercial Launch in Qatar

20/11/2018 - 14:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes [...]

IntelGenx Announces FDA’s Acceptance of Resubmission of New Drug Application for RIZAPORT®

20/11/2018 - 14:00

- PDUFA Goal Date of April 1, 2019 - SAINT LAURENT, Quebec, Nov. 20, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that its 505(b)(2) New Drug [...]

BioSig Technologies Reinvests in Lafayette College’s InternShift Progam

20/11/2018 - 14:00

Santa Monica, CA, Nov. 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Krystal Biotech to Present at Evercore ISI HealthCONx

20/11/2018 - 14:00

PITTSBURGH, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]

Immune Design to Present at Piper Jaffray 30th Annual Healthcare Conference

20/11/2018 - 14:00

SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that management will [...]

Zynerba Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference

20/11/2018 - 14:00

DEVON, Pa., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]

CymaBay Therapeutics to Participate in Upcoming Investor Conferences

20/11/2018 - 14:00

NEWARK, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Aeglea BioTherapeutics to Present at Evercore ISI HealthconX Conference

20/11/2018 - 14:00

Company to Webcast Fireside Chat on Tuesday, November 27 at 2:45 p.m. ET AUSTIN, Texas, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company that designs [...]

Inovalon to Present at the Evercore ISI HealthCONx Conference

20/11/2018 - 13:55

BOWIE, Md., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D [...]

Crinetics Pharmaceuticals to Participate in Piper Jaffray 30th Annual Healthcare Conference

20/11/2018 - 13:30

SAN DIEGO, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Strongbridge Biopharma plc Announces Presentation of New Data Comparing the In Vitro Effects of Levoketoconazole, the Active Ingredient in RECORLEV™, and Ketoconazole on Human Cortisol Production

20/11/2018 - 13:30

In Vitro Data Show Preliminary Evidence That Levoketoconazole Inhibits ACTH Secretion and May Have Anti-Tumor Effect on Pituitary Adenoma Cells First Study in Primary Human Adrenal Cells Suggests Levoketoconazole, the [...]

ProMIS Neurosciences Issues Year-to-Date Update, Highlighting 2018 Accomplishments

20/11/2018 - 13:30

Development of therapeutic antibodies for Alzheimer’s disease, Parkinson’s disease and ALS are top priorities for drug development and potential partnering TORONTO and CAMBRIDGE, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE [...]

Radient Technologies Inc. Receives Confirmation of Readiness Letter from Health Canada

20/11/2018 - 13:30

EDMONTON, Alberta, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) is pleased to announce that it has received its Confirmation of Readiness (“COR”) Letter [...]

IMV Moves to Develop DPX-Survivac as Monotherapy for Recurrent Ovarian Cancer

20/11/2018 - 13:05

IMV Will Host an Investor Call Today at 8:00 a.m. ET to Discuss the Updates to Its Clinical Program DARTMOUTH, Nova Scotia, Nov. 20, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno- [...]

Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH Meeting

20/11/2018 - 13:05

SAN DIEGO and TORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target [...]

New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted

20/11/2018 - 13:00

Oasmia Pharmaceutical AB (Nasdaq: OASM) announces that the United States Patent and Trademark Office (USPTO) has issued a notification of allowance of a patent for its unique nanotech method to produce novel [...]

BeiGene to Present at the 30th Annual Piper Jaffray Healthcare Conference

20/11/2018 - 13:00

CAMBRIDGE, Mass., and BEIJING, China, Nov. 20, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]